Question 1

What is the potential problem with bioequivalence between different brand names of medications?

Accepted Answer

A)  The colours of the preparations may be different. 
B)  The labels on the containers may be different. 
C)  Consumers may get confused about the availability of more than one preparation. 
D)  The medications may not be absorbed or act in the same way after administration. 
A)  The colours of the preparations may be different. 
B)  The labels on the containers may be different. 
C)  Consumers may get confused about the availability of more than one preparation. 
D)  The medications may not be absorbed or act in the same way after administration. D

Question 2

In Australia,there are some Schedule 3 medications that can be advertised in the popular media.One example of a medication to which this advertising policy applies is:

Accepted Answer

A)  miconazole pessaries. 
B)  ampicillin capsules. 
C)  royal jelly preparations. 
D)  codeine tablets. 
A)  miconazole pessaries. 
B)  ampicillin capsules. 
C)  royal jelly preparations. 
D)  codeine tablets. A

Question 3

What is meant by the term 'de facto direct-to-consumer advertising'?

Accepted Answer

A)  When a professional pharmacy body advertises in a popular magazine about a particular medicine. 
B)  When a professional nursing body advertises in a nursing journal about a particular medicine. 
C)  When a pharmaceutical company provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication. 
D)  When a professional pharmacy body provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication. 
A)  When a professional pharmacy body advertises in a popular magazine about a particular medicine. 
B)  When a professional nursing body advertises in a nursing journal about a particular medicine. 
C)  When a pharmaceutical company provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication. 
D)  When a professional pharmacy body provides information about specific characteristics of a particular medication in the popular media but does not mention the name of the medication. C

Question 4

The generic name of a medication is the:

Accepted Answer

A)  name given by the biochemical scientist who invented the medication. 
B)  name given to the pharmaceutical company that manufactures the medication. 
C)  chemical name of the medication. 
D)  shortened, simplified version of the chemical name. 
A)  name given by the biochemical scientist who invented the medication. 
B)  name given to the pharmaceutical company that manufactures the medication. 
C)  chemical name of the medication. 
D)  shortened, simplified version of the chemical name.

Question 5

Why is once-daily dosing preferred for Australian Indigenous peoples?

Accepted Answer

A)  Because Indigenous people generally have a poor memory. 
B)  Indigenous people have a culturally different concept of time, therefore minimising the number of doses is aimed at promoting compliance. 
C)  Because once-daily dosing is less likely to cause side effects such as renal disease. 
D)  All of the above. 
A)  Because Indigenous people generally have a poor memory. 
B)  Indigenous people have a culturally different concept of time, therefore minimising the number of doses is aimed at promoting compliance. 
C)  Because once-daily dosing is less likely to cause side effects such as renal disease. 
D)  All of the above.

Question 6

The brand name of a medication is provided by the:

Accepted Answer

A)  government. 
B)  pharmaceutical company. 
C)  biochemical scientist who invented the medication. 
D)  drug evaluation committee that formally examines all data about medications. 
A)  government. 
B)  pharmaceutical company. 
C)  biochemical scientist who invented the medication. 
D)  drug evaluation committee that formally examines all data about medications.

Question 7

It is best to learn about pharmacology with reference to what particular type of medication names?

Accepted Answer

A)  Chemical names 
B)  Brand names 
C)  Generic names 
D)  Proprietary names 
A)  Chemical names 
B)  Brand names 
C)  Generic names 
D)  Proprietary names

Question 8

Which of the following health professionals can decrease the incidence of polypharmacy?

Accepted Answer

A)  Medical practitioner 
B)  Pharmacist 
C)  Nurse 
D)  All of the above 
A)  Medical practitioner 
B)  Pharmacist 
C)  Nurse 
D)  All of the above

Question 9

A key feature of polypharmacy is:

Accepted Answer

A)  self-diagnosing and medicating. 
B)  using many different pharmacies to purchase medicines. 
C)  the excessive or unnecessary use of medicines. 
D)  a reluctance to use complementary therapies. 
A)  self-diagnosing and medicating. 
B)  using many different pharmacies to purchase medicines. 
C)  the excessive or unnecessary use of medicines. 
D)  a reluctance to use complementary therapies.

Question 10

For clients from culturally and linguistically diverse backgrounds,the health professional should assess

Accepted Answer

A)  the client's beliefs and values. 
B)  self-treatment by home remedies or concurrent use of traditional medicines with conventional medicines. 
C)  concerns about drug therapy and/or invasive procedures. 
D)  all of the above. 
A)  the client's beliefs and values. 
B)  self-treatment by home remedies or concurrent use of traditional medicines with conventional medicines. 
C)  concerns about drug therapy and/or invasive procedures. 
D)  all of the above.

Question 11

Which of the following acne preparations CANNOT be purchased as an over-the-counter preparation?

Accepted Answer

A)  An isotretinoin preparation 
B)  A sulphur preparation 
C)  A resorcinol preparation 
D)  A benzoyl peroxide preparation 
A)  An isotretinoin preparation 
B)  A sulphur preparation 
C)  A resorcinol preparation 
D)  A benzoyl peroxide preparation

Question 12

Patients taking OTC and complementary medication may:

Accepted Answer

A)  have adverse drug interactions if they are also taking prescription medications. 
B)  not discuss the OTC or complementary medicines with their health professional as they do not consider them important. 
C)  attempt self-diagnosis and treatment prior to consulting their professional. 
D)  all of the above. 
A)  have adverse drug interactions if they are also taking prescription medications. 
B)  not discuss the OTC or complementary medicines with their health professional as they do not consider them important. 
C)  attempt self-diagnosis and treatment prior to consulting their professional. 
D)  all of the above.

Exam 1: Sociocultural Aspects

What is the potential problem with bioequivalence between different brand names of medications?

In Australia,there are some Schedule 3 medications that can be advertised in the popular media.One example of a medication to which this advertising policy applies is:

What is meant by the term 'de facto direct-to-consumer advertising'?

The generic name of a medication is the:

Why is once-daily dosing preferred for Australian Indigenous peoples?

The brand name of a medication is provided by the:

It is best to learn about pharmacology with reference to what particular type of medication names?

Which of the following health professionals can decrease the incidence of polypharmacy?

A key feature of polypharmacy is:

For clients from culturally and linguistically diverse backgrounds,the health professional should assess

Which of the following acne preparations CANNOT be purchased as an over-the-counter preparation?

Patients taking OTC and complementary medication may:

Health Professionals and the Law

Ethical Issues

the Roles and Responsibilities of Health Professionals in Medicine Adherence, Education and Advocacy

the Roles and Responsibilities of Health Professionals in Medicine Management

Medicine Formulations, Storage and Routes of Administration

the Clinical Decision-making Process

Medicine Administration Strategies and Documentation

Medication Errors

Management of Common Adverse Drug Reactions

Risk Communication: Balancing the Benefits and Risks of Drug Treatment

Drug Nomenclature

Pharmacokinetics: Absorption and Distribution

Pharmacokinetics Metabolism and Excretion

Drug Interactions

Pharmacodynamics

Drug Development, Evaluation and Safety

Genetic Considerations in Pharmacology

Pharmacokinetic Factors That Modify Drug Action

Paediatric and Geriatric Pharmacology

Poisoning and Envenomation

the Management of Acute Clinical Overdose

Contemporary Drugs of Abuse

Drug Abuse in Sport

General Aspects of Neuropharmacology

Adrenergic Pharmacology

Cholinergic Pharmacology

An Introduction to Chemical Mediators

Histamine and Antihistamines

Prostaglandins and Serotonin

Nitric Oxide and the Endothelins

General concepts of Psychopharmacology

Antipsychotics

Anxiolytics and Hypnotics

Antidepressants and Mood Stabilisers

Medicines Used in Neurodegenerative Disorders

Antiseizure Agents and Muscle Relaxants

Central Nervous System Stimulants

Opioid Analgesics

Anti-inflammatory, Antipyretic and Non-opioid Analgesic Agents

Medicines Used to Treat Migraine

General Anaesthesia

Local Anesthesia

Medicines Used to Lower Blood Lipids

Antihypertensive Agents

Medicines Used to Promote Tissue Perfusion

Antithrombotic, Fibrinolytic and Haemostatic Agents

Diuretics and Other Renal Medicines

Topic: Medicines Used to Treat Heart Failure

Medicines Used to Treat Cardiac Dysrhythmia

Fluid and Potassium Imbalances

Antianaemic Agents

Medicines Used to Maintain Gas Exchange

Medicines for Upper Respiratory Tract Conditions

Upper Gastrointestinal Tract Medicines

Lower Castrointestinal Tract Medicines

Antiemetic Agents

Enteral and Parenteral Nutrition

Medicines and the Pituitary Gland

Medicines and the Thyroid

Medicines and the Pancreas

Medicines Affecting the Adrenal Cortex

Medicines and the Gonads

Medicines and Bone Metabolism

Hyperuricaemia and Gout

Obesity and Its Treatment

Introduction to Chemotherapy

Sulfonamides and Trimethoprim